title: Fitting new technologies into the safety paradigm: use of microarrays in transfusion.
abstract: Until the late 1990s, mandatory blood screening for transmissible infectious agents depended entirely on antigen/antibody-based detection assays. The recent emergence of Nucleic acid Amplification Technologies (NAT) has revolutionised viral diagnosis, not only by increasing the level of sensitivity but also by facilitating the detection of several viruses in parallel by multiplexing specific primers. In more complex biological situations, when a broad spectrum of pathogens must be screened, the limitations of these first generation technologies became apparent. High throughput systems, such as DNA Arrays, permit a conceptually new approach. These miniaturised micro systems allow the detection of hundreds of different targets simultaneously, inducing a dramatic decrease in reagent consumption, a reduction in the number of confirmation tests and a simplification of data interpretation. However, the systems currently available require additional instrumentation and reagents for sample preparation and target amplification prior to detection on the DNA array. A major challenge in the area of DNA detection is the development of methods that do not rely on target amplification systems. Likewise, the advances of protein microarrays have lagged because of poor stability of proteins, complex coupling chemistry and weak detection signals. Emerging technologies like Biosensors and nano-particle based DNA or Protein Bio-Barcode Amplification Assays are promising diagnostic tools for a wide range of clinical applications, including blood donation screening.
authors.affiliation: Transfusion Transmitted Infectious Diseases R&D Unit, EFS Pyrénées Méditerranée, Montpellier, France.
authors.forename: C
authors.initials: C
authors.lastname: Fournier-Wirth
authors.forename: J
authors.initials: J
authors.lastname: Coste
mesh_terms: D000094902:Blood Banking / Q000379:methods*; D001803:Blood Transfusion / Q000379:methods*; D006801:Humans; D008403:Mass Screening / Q000379:methods* / Q000639:trends; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods* / Q000639:trends; D040081:Protein Array Analysis / Q000379:methods* / Q000639:trends; D014780:Viruses / Q000235:genetics*